NFL Biosciences SA (EPA:ALNFL)
France · Delayed Price · Currency is EUR 1.334
-0.006 (-0.45%)
Jan 9, 2026, 5:29 PM CET
NFL Biosciences Market Cap
NFL Biosciences has a market cap or net worth of €16.9 million as of January 9, 2026. Its market cap has decreased by -9.28% in one year.
Market Cap
16.90M
Enterprise Value
14.83M
Revenue
164.00
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.33
Market Cap Chart
Since July 5, 2021, NFL Biosciences's market cap has decreased from 19.47M to 16.90M, a decrease of -13.19%. That is a compound annual growth rate of -3.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 16.98M | 13.75% |
| Dec 31, 2025 | 14.93M | -21.92% |
| Dec 31, 2024 | 19.12M | 63.78% |
| Dec 29, 2023 | 11.67M | 13.49% |
| Dec 30, 2022 | 10.29M | -18.13% |
| Dec 31, 2021 | 12.56M | -35.48% |
| Jul 5, 2021 | 19.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 125.76B |
| Sanofi | 100.86B |
| Sartorius Stedim Biotech | 21.47B |
| bioMérieux | 13.42B |
| Eurofins Scientific SE | 12.17B |
| Ipsen | 10.40B |
| ABIVAX Société Anonyme | 7.72B |
| Virbac | 3.03B |